-
Mashup Score: 1New test helps drug discoverers identify future cancer treatments - 6 month(s) ago
Researchers have developed an investigative procedure that makes the early stages of drug discovery more efficient.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Drug discovery in epilepsy began with the finding of potassium bromide by Sir Charles Locock in 1857. The following century witnessed the introduction of phenotypic screening tests for discovering an…
Source: onlinelibrary.wiley.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0AI biotech company Genesis scores $200M to advance drug discovery - 7 month(s) ago
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.
Source: www.mobihealthnews.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Precision Healthcare Revolution: Unleashing AI's potential — Interview with Carlos Ciller, CEO and Co-founder of RetinAI - 8 month(s) ago
RetinAI is making waves in the healthcare industry with its mission to enable informed decisions sooner in healthcare. Through its innovative AI-powered image analysis platform, RetinAI facilitates drug discovery, clinical studies, and patient care. Venturelab invites you to join us and Carlos, as the future of healthcare is being reshaped and RetinAI continues to expand its AI prowess into diverse medical domains.
Source: www.venturelab.swissCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 04 most promising healthcare generative AI startups, per CB Insights - 8 month(s) ago
Discover the 4 most promising generative AI startups in healthcare, as identified by CB Insights. Learn about Aqemia, Hippocratic AI, Navina, and Subtle Medical.
Source: www.beckershospitalreview.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1How to Apply | NExT - 8 month(s) ago
Last Updated: 01/11/23 Overview The NCI Experimental Therapeutics (NExT) pipeline is designed to assist translation to the clinic of novel therapeutic interventions, either synthetic, natural product, or biologic, arising from academic, private, or government entities. NExT is not a grant mechanism. Approved proposals gain access to drug discovery resources and development…
Source: next.cancer.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2 - Nature Communications - 9 month(s) ago
There are currently two types of antiviral drugs – neutralizing antibodies and small molecule inhibitors. Here, the authors report the development of bicyclic peptides that combine the advantages of both and show their antiviral capacity against SARS-CoV-2 in vitro as well as in small animal models.
Source: NatureCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1
Researchers are set to to combine expertise in drug discovery, artificial intelligence (AI), and experimental cancer models and platforms in a new programme to design the precision cancer drugs of the future.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The 3 Hottest Areas for Healthcare Generative AI - MedCity News - 9 month(s) ago
There are three key areas of the healthcare sector where generative AI is booming the most — in terms of both venture capital funding and the development of innovative technology — according to Anjalika Komatireddy, an analyst at CB Insights. During a recent webinar, she discussed the generative AI activity occurring in these three areas: care delivery and navigation, digital therapeutics and…
Source: MedCity NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2 - Nature Communications - 9 month(s) ago
There are currently two types of antiviral drugs – neutralizing antibodies and small molecule inhibitors. Here, the authors report the development of bicyclic peptides that combine the advantages of both and show their antiviral capacity against SARS-CoV-2 in vitro as well as in small animal models.
Source: NatureCategories: General Medicine News, Latest HeadlinesTweet
💬“We're confident that this procedure will become part of the standard #DrugDiscovery workflow. We hope it will benefit the wider drug discovery community.'' - Dr Maggie Liu, Senior Scientific Officer in the ICR's Medicinal Chemistry 4 Team Read more⬇️ https://t.co/yr1fgh5xXo https://t.co/uyrH5TIa70